KRBP
Kiromic BioPharma (KRBP)
$92
About Kiromic BioPharma (KRBP)
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Details
Daily high
$1.12
Daily low
$0.92
Price at open
$1.10
52 Week High
$3.78
52 Week Low
$0.31
Market cap
1.4M
Dividend yield
0.00%
Volume
10,829
Avg. volume
1,353
P/E ratio
-.04
Kiromic BioPharma News
Details
Daily high
$1.12
Daily low
$0.92
Price at open
$1.10
52 Week High
$3.78
52 Week Low
$0.31
Market cap
1.4M
Dividend yield
0.00%
Volume
10,829
Avg. volume
1,353
P/E ratio
-.04